US Pharma MarketingWith Cencora pact, Gilead looks to grow CAR-T treatment center network
Pharma solutions firm Cencora and Gilead Sciences have expanded Cencora and Gilead have expanded their longstanding partnership, cutting a deal in which the distribution giant will support access to the CAR-T cancer therapies Yescarta and Tecartus.
Cencora and Gilead have expanded their longstanding partnership, cutting a deal in which the distribution giant will support access to the CAR-T cancer therapies Yescarta and Tecartus.
Source: FiercePharma